Maynard Um
-
-
-
-
-
-
-
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25
-
-
-
-
-
-
-
Cingulate Inc (CING): Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD
-
-
-
-
-
-
-
Cingulate Inc (CING) Files for 1.5M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
Cingulate (CING) Achieves Key Manufacturing Milestone in the Development of CTx-1301
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

